 |
ArchiveSmall-Cap Pain Stocks Follow King After Pfizer Deal (PFE, KG, PTIE, ACUR, ENDP, DRRX, CPIX, OMER)Posted by Jason Smith at 10:50AM on October 12th
Pharmaceutical giant Pfizer (PFE) sent King Pharmaceuticals (KG) soaring on Tuesday after agreeing to buy the firm for $3.6 billion or $14.25 per share in cash, a 40% premium to King’s closing value on Monday. The acquisition will expand Pfizer’s exposure to…  Clarity Sends Financials Higher, Ultimate Reform Impact Unknown (ORCL, AVAV, RIMM, ACN, OMER)Posted by Geoff Seiler at 4:47PM on June 25th
The passage of the financial regulation bill was the big news of the day. While banks rallied by and large, it was mainly due to a resolution than anything else. Some of the harshest proposals were either not in the… Select Healthcare Stocks Float Higher Amid Broad Sell-Off (OSIR, NBS, CUR, KOOL, GERN, CPIX, OMER, DRRX, MIPI, MNKD)Posted by Jason Smith at 2:58PM on June 24th
Various segments of the healthcare industry staged a low-volume rally on Thursday as the major market benchmarks traded in the red. As a whole, the Stem Cell Stocks Index is ahead by 3% for the session as Osiris Therapeutics (OSIR) and Neostem (NBS) soar… |
|
Follow us on
  |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |